Renal Denervation for the Treatment of Hypertension: A Scientific Statement From the American Heart Association
JL Cluett, O Blazek, AL Brown, C East… - …, 2024 - ahajournals.org
Hypertension is a leading risk factor for cardiovascular morbidity and mortality. Despite the
widespread availability of both pharmacological and lifestyle therapeutic options, blood …
widespread availability of both pharmacological and lifestyle therapeutic options, blood …
Impact of renal denervation on quality of life how does renal denervation contribute to improving hypertension treatment affected by poor medication adherence?
K Okamura, H Shimada, K Imazato, H Sako… - Hypertension …, 2024 - nature.com
Abstract The US Food and Drug Administration has approved renal denervation (RDN) as a
new treatment option for hypertension (HT) because it not only has antihypertensive effects …
new treatment option for hypertension (HT) because it not only has antihypertensive effects …
Differences in the effectiveness and safety of different renal denervation devices
Y Ogoyama, K Kario - Hypertension Research, 2024 - nature.com
Renal denervation (RDN) is a minimally invasive, endovascular catheter-based procedure
using radiofrequency, ultrasound, or alcohol-mediated ablation to treat resistant …
using radiofrequency, ultrasound, or alcohol-mediated ablation to treat resistant …
Bayliss Starling Prize Lecture 2023: Neuropeptide‐Y being 'unsympathetic'to the broken hearted
Abstract William Bayliss and Ernest Starling are not only famous as pioneers in
cardiovascular physiology, but also responsible for the discovery of the first hormone (from …
cardiovascular physiology, but also responsible for the discovery of the first hormone (from …
[HTML][HTML] Advances in Cardiorenal Medicine: The Year 2023 in Review
A Kazory, C Ronco - Cardiorenal Medicine, 2024 - karger.com
In 2023, there were several new developments in the field of cardionephrology with potential
impact on the care of patients with dual burden of heart and kidney disease. With new drugs …
impact on the care of patients with dual burden of heart and kidney disease. With new drugs …
The Next Chapter of Renal Denervation After US Food and Drug Administration Approval
W Vongpatanasin, T Addo - Circulation, 2024 - Am Heart Assoc
The US Food and Drug Administration recently approved 2 renal denervation (RDN)
systems, the ultrasound-based RDN (uRDN, Recor Paradise) and the multipolar …
systems, the ultrasound-based RDN (uRDN, Recor Paradise) and the multipolar …
Renal Artery Denervation for the Management of Hypertension: Current Trends and Future Direction
SY Naqvi, MU Shah, M Renner, A Kouloumpinis… - The American Journal of …, 2024 - Elsevier
Renal artery denervation has re-emerged as a potential therapeutic option for patients with
hypertension, especially those resistant to conventional pharmacotherapy. This …
hypertension, especially those resistant to conventional pharmacotherapy. This …
[HTML][HTML] Renal Denervation for Hypertension: The Current Landscape and Future Directions
B Fulton, J Giri, F Rader, DL Cohen… - Heart …, 2024 - ncbi.nlm.nih.gov
Hypertension (HTN) is one of the largest contributors to cardiovascular (CV) morbidity and
mortality in the USA and is estimated to affect 47% of the US population; however, recent …
mortality in the USA and is estimated to affect 47% of the US population; however, recent …
HASH (0x558738bd71e8)
G Goetz, D Giess, J Kern - 2024 - eprints.aihta.at
Abstract Treatment-resistant hypertension (TRH) is diagnosed when blood pressure remains
above 140/90 mmHg systolic/diastolic despite lifestyle changes and the use of at least three …
above 140/90 mmHg systolic/diastolic despite lifestyle changes and the use of at least three …
Letter by Zhang et al Regarding Article,“Patient-Level Pooled Analysis of Endovascular Ultrasound Renal Denervation or a Sham Procedure 6 Months After …
Z Zhang, K Liu, X Chen - Circulation, 2024 - ahajournals.org
Azizi M, Sharp ASP, Fisher NDL, Weber MA, Lobo MD, Daemen J, Lurz P, Mahfoud F,
Schmieder RE, Basile J, et al; RADIANCE Investigators. Patient-level pooled analysis of …
Schmieder RE, Basile J, et al; RADIANCE Investigators. Patient-level pooled analysis of …